Risk factors
Catheter Precision (VTAK) risk factors
Item 1A of every Catheter Precision, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors53 risks1 new2 dropped5 reworded
Marketing and distribution support is now separately identified as a threat to product acceptance and revenue.
Filed Mar 31, 2026 - FY2024 10-K risk factors54 risks
Catheter Precision faces going-concern doubts due to persistent cash burn and operating losses from its VIVO System and LockeT products. The company must secure additional funding, build a U.S. sales force, and expand FDA clearances to reach profitability. Pervasive FDA regulations, material financial control weaknesses, and reimbursement hurdles pose ongoing threats.
Filed Mar 31, 2025